A judge has temporarily excused uranium miner Paladin Energy from providing initial discovery in a shareholder class action, as the parties wait for a competing class action to be filed.
The ATO has won its challenge to a finding that it waived privilege over draft expert reports in an email referring to its contents, with a court saying disclosure of the substance of information is not per se inconsistent with maintaining privilege.
HSBC has hit back at ASIC’s claims that it failed to protect customers from scams, denying it breached its legislative duties despite admitting some of the regulator’s allegations concerning its compliance with the ePayments code, a voluntary code of conduct.
Gaming company Light & Wonder has hit back at Aristocrat’s intellectual property case, arguing that allegedly confidential information about the popular Dragon Link poker game was not trade secrets.
Sharvain Façades has won extra time to convene a second creditors’ meeting to pursue a $3.28 million win against Roberts Co, but not based on the argument that SOPA says its liquidation would bar enforcement of the judgment.
A dispute over a scuppered transaction between the director of collapsed Keystone and the owner of the Marriott Hotel in Venice has been settled.
With three months until trial, a judge has knocked back a former ANZ trader’s bid to appeal a decision which barred him from amending his case for what would have been the thirteenth time.
The state of Victoria has sounded alarm bells about an amendment application by a class action over the COVID-19 hotel quarantine debacle, telling a judge it amounts to a new case with an “infinite number of permutations”.
Green iron start-up Element Zero has said it will fight Fortescue’s bid to access nearly nine million documents collected under a controversial search order in the mining giant’s case alleging former employees misappropriated its process for carbon dioxide-free iron.
Monash IVF has won an injunction against its former chief operating officer, who departed after the fertility company’s embryo mix-up came to light, that limits his participation in his new employer’s Australian operations.